Side effects of azathioprine treatment given for inflammatory bowel disease - A 30 year audit.

被引：5
|
作者：
Fraser, AG [1 ]
Jewell, DP [1 ]
机构：
[1] John Radcliffe Hosp, Dept Gastroenterol, Oxford OX3 9DU, England
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)85289-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4201
引用
收藏
页码：A787 / A787
页数：1
相关论文
共 50 条
  • [41] Azathioprine in the treatment of chronic inflammatory bowel diseases
    Herrlinger, K
    Stange, EF
    MEDIZINISCHE KLINIK, 2000, 95 (04) : 201 - 206
  • [42] TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects
    Steponaitiene, Ruta
    Kupcinskas, Juozas
    Survilaite, Santa
    Varkalaite, Greta
    Jonaitis, Laimas
    Kiudelis, Gediminas
    Denapiene, Goda
    Valantinas, Jonas
    Skieceviciene, Jurgita
    Kupcinskas, Limas
    ADVANCES IN MEDICAL SCIENCES, 2016, 61 (01): : 135 - 140
  • [43] Ocular Toxoplasmosis Reactivation in a Patient With Inflammatory Bowel Disease Under Treatment With Azathioprine
    Puga, Manuel
    Carpio, Daniel
    Sampil, Marta
    Jose Zamora, Maria
    Fernandez-Salgado, Estela
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2016, 50 (07) : 610 - 610
  • [44] Relapse rates on and after stopping azathioprine treatment for inflammatory bowel disease.
    Fraser, AG
    Jewell, DP
    GASTROENTEROLOGY, 2000, 118 (04) : A786 - A786
  • [45] Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine
    Nielsen, OH
    Vainer, B
    Rask-Madsen, J
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (11) : 1699 - 1708
  • [46] Mercaptopurine treatment should be considered in azathioprine intolerant patients with inflammatory bowel disease
    Hindorf, U.
    Johansson, M.
    Eriksson, A.
    Kvifors, E.
    Almer, S. H. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (06) : 654 - 661
  • [47] Faecal calprotectin falls in response to treatment of inflammatory bowel disease with azathioprine or steroids
    Smale, S
    Foster, R
    Bjarnason, I
    GASTROENTEROLOGY, 2002, 122 (04) : A78 - A78
  • [48] Should azathioprine and 5-aminosalicylates be coprescribed in inflammatory bowel disease?: an audit of adverse events and outcome
    Shah, Jayshri A.
    Edwards, Cathryn M.
    Probert, Chris S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (03) : 169 - 173
  • [49] INFLAMMATORY BOWEL DISEASES AND PRIMARY SCLEROSING CHOLANGITIS: HEPATIC AND PANCREATIC SIDE EFFECTS DUE TO AZATHIOPRINE
    Pallavicino, F.
    Pellicano, R.
    Reggiani, S.
    Simondi, D.
    Garavagno, M.
    Bonagura, G.
    La Terra, A.
    Sapone, N.
    Rizzetto, M.
    Astegiano, M.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S174 - S174
  • [50] Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine
    Pallavicino, F.
    Pellicano, R.
    Reggiani, S.
    Simondi, D.
    Sguazzini, C.
    Bonagura, A. G.
    Cisaro, F.
    Rizzetto, M.
    Astegiano, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (01) : 84 - 87
12345